Drug Discovery

Home › Portfolio › Drug Discovery › Immunomic Therapeutics, Inc.

Immunomic Logo

Immunomic Therapeutics, Inc., (ITI) is a clinical stage biotechnology company with a novel technology called LAMP-vax for application to vaccines and vaccine immunotherapies.  LAMP-vax promises to increase the effectiveness of the immune response to DNA vaccines while simplifying overall vaccine design and delivery. The technology is ideally suited for application to allergy immunotherapy.

www.immunomix.com

CEO and Chairman
William G. Hearl, Ph.D.

Location
Lancaster, PA

  • The Funding Process

    The Funding Process

    The Life Sciences Greenhouse of Central Pennsylvania provides investment funding up to $1 million in milestone-driven convertible…

    Read more

  • Our Resource Center

    tomb2

    It’s a familiar scenario. You hear about a discovery that could lead to the cure for this disease or that debilitating…

    Read more

  • The 'PA' in LSGPA

    tomb3

    The Life Sciences Greenhouse of Central Pennsylvania’s 42-county service area contains more than 60 institutions of higher …

    Read more